Logo image
Back
Cardioneuroablation for Ictal Asystole: A Multicenter Case Series
Journal article   Open access   Peer reviewed

Cardioneuroablation for Ictal Asystole: A Multicenter Case Series

John H Bertot, Tolga Aksu, Henry Huang, Victor Neira, Matthew Hanson, Matthew Hyman, Dan Wichterle, Bor Antolič, Mauricio Scanavacca, Carina Hardy, …
JACC. Clinical electrophysiology
04/23/2026
DOI: 10.1016/j.jacep.2026.04.002
PMID: 42024564
url
https://doi.org/10.1016/j.jacep.2026.04.002View
Published (Version of record) Open Access

Abstract

Cardioneuroablation (CNA) is an emerging therapy for vagally mediated bradyarrhythmias. Its role in ictal asystole, a rare but severe manifestation of epilepsy, remains poorly defined. Summarize procedural characteristics and clinical outcomes of CNA performed for ictal asystole. We conducted a retrospective, multicenter study across six international centers, identifying adult patients who underwent CNA for ictal asystole (≥ 4 s) from 2017 to 2025. Twelve patients (aged 39 ± 9 years; 50% female) were included; 9/12 had focal impaired-awareness seizures. All patients exhibited sinus arrest during the events, with a mean asystole of 16 ± 8 s, and a median number of 7 syncopal events. Biatrial CNA (75% under conscious sedation) was facilitated by 3D electroanatomic mapping. Ganglionated plexi (GP) were identified using anatomical landmarks and fractionated electrograms. Right superior (12/12), right inferior (10/12), and left inferior (9/12) GPs were most frequently ablated. After CNA, the sinus rate increased by ≥ 25% in 10/12 patients, and 9/12 demonstrated a blunted atropine response. No procedural complications occurred. Over a median follow-up of 20.5 months, 8/12 patients remained free from ictal asystole. Four patients experienced recurrent syncope at 2-15 months and underwent repeat CNA, with one of them achieving durable freedom from syncope. Two patients ultimately required a pacemaker implant. In patients with ictal asystole, biatrial CNA appears safe and may substantially reduce syncope burden, although repeat ablation or permanent pacing may be required. Prospective studies are needed to better define efficacy and long-term outcomes.
 Epilepsy vasovagal syncope Ablation functional bradyarrhythmias

Details

Metrics

1 Record Views
Logo image